Rehabilitation of People With Post-tuberculosis Lung Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentro Universitário Augusto Motta

About this trial

Tuberculosis (TB) can leave numerous sequelae, where survivors experience a transition from an acute illness to living with a multifaceted chronic illness. Post-TB lung disease (PD-PTB) encompasses lung diseases and pathologies that occur after one or more episodes of TB, which can affect the patient's lung health and cause disabling symptoms that strongly affect their long-term health. In 2020, it was estimated that there were 155 million TB survivors still alive worldwide, with a large proportion of them carrying functional sequelae with profound socioeconomic repercussions. Thus, the aim of this study is to evaluate the effect of pulmonary rehabilitation (PR) on functionality and health-related quality of life (HRQoL) of people with PD-PTB and to build a PD-PTB severity scoring system based on the data. of pre-RP individuals using artificial intelligence technique.

Eligibility criteria

Qualifiers

Patients with post-tuberculosis lung disease, clinically stable and able to perform >80% of training sessions.

Disqualifiers

Presence of comorbidities not related to PD-PTB.

Patients with inability to perform TGlittre.

Patients who have cognitive changes that impair their inclusion in the study.

Treatment abandonment during the application of the PR protocol.

Trial design

Treatments tested in this trial

  • Standard care plus pulmonary rehabilitation
  • Standard Care

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Centro Universitário Augusto Motta

Lead sponsor

Rio de Janeiro State University

Collaborator